Search

Your search keyword '"Villari, D."' showing total 409 results
Start Over Author "Villari, D."
409 results on '"Villari, D."'

53. Endoscopic management of acquired cholesteatoma: our experience

Author

Presutti L, Daniele MARCHIONI, Mattioli F, Villari D, Alicandri-Ciufelli M, Presutti, Livio, Marchioni, Daniele, Mattioli, Francesco, Villari, Domenico, and Alicandri-Ciufelli, Matteo

Subjects
Adult, Male, Cholesteatoma, Middle Ear, Middle Ear, Endoscopy, Acquired cholesteatoma, Treatment Outcome, otorhinolaryngologic diseases, Female, Humans, Cholesteatoma, Human
Abstract

Objectives: The purpose of this study was to examine the utility of using an endoscope in cholesteatoma surgery and to demonstrate how it allows a reduction in the incidence of residual disease. Material and methods: Thirty-two ears with acquired cholesteatoma (primary) were resected. Twenty cases were resected using a canal wall up (CWU) technique and six cases using a canal wall down (CWD) technique, and in six cases, a transcanal tympanotomy-atticotomy was performed. All of the patients in our study group underwent explorative and operative endoscopic ear surgery complementary to use of the operating microscope to uncover and remove residual cholesteatoma. Results: In the primary surgery after completion of microscopic cleaning, the overall incidence of intraoperative residual disease detected with the endoscope was 37.5%. The sinus tympani was the most common site of intraoperative residual disease, followed by the anterior epitympanic recess and protympanum. Of the 20 CWU cases, 12 second-look endoscopies were performed. Two residuals were identified, both in the sinus tympani. No significant complications were associated with the 32 endoscopic procedures. Conclusion: The endoscope allowed a better understanding of cholesteatoma and improved eradication of residual disease from hidden areas such as the anterior epitympanic recess, retrotympanum, and hypotympanum not yet controllable by the operating microscope.

Published
2008

58. La chirurgia endoscopica nell’atresia coanale

Author

Presutti, L, Villari, D, Masoni, F, Bergamini, G, Marchioni, Daniele, and L. Presutti, D. Villari, F. Masoni, G. Bergamini, D. Marchioni

Subjects
atresia coanale, Chirurgia endoscopica, atresia coanale, Chirurgia endoscopica
Published
2007

65. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease

Author

Tuccari, G., Villari, D., Giuffre, G., Simone, A., Squadrito, G., Raimondo, G., and Barresi, G.

Subjects
Adult, Cell Nucleus, Male, Cytoplasm, Hepatitis B Surface Antigens, Hepatitis, Viral, Human, Chronic liver disease, 6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología [CDU], virus diseases, Liver biopsy, Middle Aged, Hepatitis B, Hepatitis C, Immunohistochemistry, Hepatitis, Lactoferrin, Liver, Hepatocytes, Humans, LACTOFERRIN, Female, Coloring Agents, Aged, Hepatitis, Chronic
Abstract

Lactoferrin (Lf) expression has been immunohistochemically investigated in 117 formalinfixed paraffin-embedded liver bioptic samples obtained from an equal number of patients affected by chronic hepatitis (HCV=76; HBV=17; HBV+HDV=14; cryptogenetic=10); in addition, 10 autoptic specimens of normal liver were studied as control. The Lf immunoreactivity was evaluated by an intensitydistribution (ID) score. The Lf immunoexpression was observed in 88 out of 117 (75%) cases of chronic hepatitis; interestingly, all liver specimens from HBV hepatitis showed a constant Lf reactivity with the highest ID-score, whereas the evidence of Lf was encountered in 54/76 (71.1%) HCV as well as in 11/14 (78.6%) HDV chronic hepatitis, thus documenting a variable degree of Lf immunostaining in relation to different viruses. Moreover, in 6/10 (60%) cases of cryptogenetic hepatitis Lf immunoexpression was documented, whereas all normal liver controls were unreactive. In HCV specimens, the Lf nuclear immunoreactivity appeared to increase with the progression of the disease, with a greater expression in genotype 1. In contrast, no relationship among Lf ID-scores and different stages or grades of HBV, HDV or cryptogenetic hepatitis was encountered. This fact may suggest a role for Lf as an unspecific defensive agent in chronic inflammatory liver diseases, similarly to that elsewhere reported in other inflammatory tissue injuries.

Published
2002

82. Transplantation: basic science

Author

Cantaluppi, V., primary, De Lena, M., additional, Beltramo, S., additional, Ferrario, S., additional, Dellepiane, S., additional, Figliolini, F., additional, Bruno, S., additional, Biancone, L., additional, Segoloni, G. P., additional, Tetta, C., additional, Camussi, G., additional, Prasad, N., additional, Jaisawal, A., additional, Yadav, B., additional, Agarwal, V., additional, Tripathi, D., additional, Nunez-Lozano, R., additional, Quiros, Y., additional, Sanchez-Gonzalez, P., additional, Perez de Obanos, M. P., additional, Ruiz, J., additional, Lopez-Hernandez, F. J., additional, Lopez-Novoa, J. M., additional, Yang, J. W., additional, Kim, J. S., additional, Lee, J. Y., additional, Park, H. C., additional, Han, B. G., additional, Choi, S. O., additional, Matsuyama, M., additional, Yoshimura, R., additional, Hayama, T., additional, Chargui, J., additional, Touraine, J.-L., additional, Yoshimura, N., additional, Zanazzi, M., additional, Carta, P., additional, Caroti, L., additional, Antognoli, G., additional, Pinzani, P., additional, Salvianti, F., additional, Villari, D., additional, Minetti, E., additional, Genina, A., additional, Ismail, W., additional, Soliman, A., additional, Ucar, H., additional, Akbas, H. S., additional, Yilmaz, V. T., additional, Aktas, A., additional, Suleymanlar, G., additional, Yucel, G., additional, Cappuccilli, M. L., additional, La Manna, G., additional, Capelli, I., additional, Baraldi, O., additional, Cuna, V., additional, Battaglino, G., additional, Todeschini, P., additional, Feliciangeli, G., additional, Scolari, M. P., additional, Stefoni, S., additional, Loiacono, E., additional, Votta, B., additional, Amore, A., additional, Ranghino, A., additional, Camilla, R., additional, Peruzzi, L., additional, Donadio, M. E., additional, Serriello, I., additional, Gallo, R., additional, Puccinelli, M. P., additional, Coppo, R., additional, Sahin, G., additional, Meltem Akay, O., additional, Uslu, S., additional, Bal, C., additional, Ugur Yalcin, A., additional, Gulbas, Z., additional, and George, J., additional

Published
2013
Full Text
View/download PDF

96. MP-04.04

Author

Li Marzi, V., primary, Del Popolo, G., additional, Filocamo, M., additional, Villari, D., additional, Marzocco, M., additional, Delle Rose, A., additional, and Nicita, G., additional

Published
2006
Full Text
View/download PDF

98. Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial

Author

Neri, B., primary, Cipriani, G., additional, Fulignati, C., additional, Turrini, M., additional, Ponchietti, R., additional, Bartoletti, R., additional, Della Melina, A., additional, Di Cello, V., additional, Dominici, A., additional, Maleci, D., additional, Raugei, A., additional, Villari, D., additional, and Nicita, G., additional

Published
2005
Full Text
View/download PDF

99. Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia

Author

Crescioli, C, primary, Ferruzzi, P, additional, Caporali, A, additional, Scaltriti, M, additional, Bettuzzi, S, additional, Mancina, R, additional, Gelmini, S, additional, Serio, M, additional, Villari, D, additional, Vannelli, GB, additional, Colli, E, additional, Adorini, L, additional, and Maggi, M, additional

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results